Compare VALN & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VALN | CLDT |
|---|---|---|
| Founded | 2012 | 2009 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 582.2M | 635.6M |
| IPO Year | 2021 | 2009 |
| Metric | VALN | CLDT |
|---|---|---|
| Price | $5.70 | $13.61 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 4 |
| Target Price | $12.25 | ★ $14.17 |
| AVG Volume (30 Days) | 21.9K | ★ 219.5K |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 2.93% |
| EPS Growth | N/A | ★ 275.00 |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $295,075,000.00 |
| Revenue This Year | N/A | $7.82 |
| Revenue Next Year | $87.65 | $3.44 |
| P/E Ratio | ★ N/A | $610.21 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.75 | $6.08 |
| 52 Week High | $12.18 | $14.05 |
| Indicator | VALN | CLDT |
|---|---|---|
| Relative Strength Index (RSI) | 39.99 | 57.59 |
| Support Level | $5.10 | $12.53 |
| Resistance Level | $6.60 | $13.80 |
| Average True Range (ATR) | 0.20 | 0.33 |
| MACD | -0.08 | 0.03 |
| Stochastic Oscillator | 23.73 | 58.49 |
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania, among others. Substantially all of the company's assets are held and operated by its operating partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. Chatham's revenue streams include room, food and beverage, and other. The room comprises the majority of its total revenue. Chatham's hotels operate under various brands, which include Hilton, Marriott, and Hyatt.